期刊
NEPHROLOGY DIALYSIS TRANSPLANTATION
卷 34, 期 8, 页码 1272-1279出版社
OXFORD UNIV PRESS
DOI: 10.1093/ndt/gfz131
关键词
Alport; autosomal; therapy; treatment; X linked
资金
- ISCIII: RETIC REDINREN [RD16/0009]
- FIS FEDER FUNDS [PI15/01824, PI18/00362]
- Catalan Government [AGAUR 2014/SGR-1441]
Alport syndrome (AS) is the most frequent inherited kidney disease after autosomal dominant polycystic kidney disease. It has three different patterns of inheritance-autosomal dominant, autosomal recessive and X-linked-which in part explains the wide spectrum of disease, ranging from isolated microhae-maturia to end-stage renal disease early in life. The search for a treatment for AS is being pursued vigorously, not only because of the obvious unmet need but also because AS is a rare disease and any drug approved will have an orphan drug designation with its various benefits. Moreover, AS patients are quite young with very few comorbidities, which facilitates clinical trials. This review identifies the particularities of each pattern of inheritance but focuses mainly on new drugs or therapeutic targets for the disease. Most treatment-related investigations are directed not at the main abnormality in AS, namely collagen IV composition, but rather at the associated inflammation and fibrosis. Thus, AS may serve as a proof of concept for numerous drugs of potential value inmany diseases that cause chronic kidney disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据